E
Edythe D. London
Researcher at University of California, Los Angeles
Publications - 492
Citations - 36481
Edythe D. London is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Nicotinic agonist & Methamphetamine. The author has an hindex of 93, co-authored 482 publications receiving 33741 citations. Previous affiliations of Edythe D. London include Icahn School of Medicine at Mount Sinai & Semel Institute for Neuroscience and Human Behavior.
Papers
More filters
Journal ArticleDOI
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
D. B. Vaupel,Alexey G. Mukhin,Alane S. Kimes,Andrew G. Horti,Andrei O. Koren,Edythe D. London +5 more
TL;DR: In this paper, a radiolabeled 5-I-5-A-85380 has excellent potential as an imaging radiotracer for nAChRs, particularly with single photon emission computed tomography, when 123I is incorporated into the molecule.
Journal ArticleDOI
Cerebral blood flow and oxidative metabolism in conscious Fischer-344 rats of different ages.
TL;DR: The results indicate that average cerebral cortical oxidative metabolism, and the coupling ratios between the cerebral metabolic rate for oxygen and cerebral blood flow and between the intellectual capacity for glucose and cerebralBlood flow, do not change significantly with age in the Fischer‐344 rat.
Journal ArticleDOI
Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study.
Michael Bauer,Steven M. Berman,Thomas Stamm,Michail Plotkin,Mazda Adli,Maximilian Pilhatsch,Edythe D. London,Gerhard Hellemann,Peter C. Whybrow,Florian Schlagenhauf +9 more
TL;DR: Evidence is provided that administration of supraphysiologic thyroid hormone improves depressive symptoms in patients with bipolar disorder by modulating function in components of the anterior limbic network.
Journal ArticleDOI
Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.
Andy C. Dean,Edythe D. London,Edythe D. London,Catherine A. Sugar,Christina M. R. Kitchen,Aimee-Noelle Swanson,Keith G. Heinzerling,Ari D. Kalechstein,Steven Shoptaw +8 more
TL;DR: Urine-verified methamphetamine abuse at the beginning of the study was the strongest predictor of treatment outcome; two psychosocial measures also offered some predictive value, but these cognitive measures did not significantly aid prediction after adjusting for methamphetamine usage.
Journal ArticleDOI
Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders
Yang Liu,Wery P. M. van den Wildenberg,Ysanne de Graaf,Susan L. Ames,Alex Baldacchino,Ragnhild Bø,Fernando Cadaveira,Salvatore Campanella,Paul Christiansen,Eric D. Claus,Lorenza S. Colzato,Francesca M. Filbey,John J. Foxe,Hugh Garavan,Christian S. Hendershot,Robert Hester,Jennifer M. Jester,Hollis C. Karoly,Anja Kräplin,Fanny Kreusch,Nils Inge Landrø,Marianne Littel,Sabine Loeber,Edythe D. London,Eduardo López-Caneda,Dan I. Lubman,Maartje Luijten,Cecile A. Marczinski,Jane Metrik,Catharine Montgomery,Harilaos Papachristou,Su Mi Park,Andres L. Paz,Géraldine Petit,James J. Prisciandaro,Boris B. Quednow,Lara A. Ray,Carl A. Roberts,Gloria Roberts,Michiel B. de Ruiter,Claudia I. Rupp,Vaughn R. Steele,Delin Sun,Michael Takagi,Susan F. Tapert,Ruth J. van Holst,Antonio Verdejo-García,Matthias Vonmoos,Marcin Wojnar,Yuan-Wei Yao,Murat Yücel,Martin Zack,Robert A. Zucker,Hilde M. Huizenga,Reinout W. Wiers +54 more
TL;DR: It is found that only lifetime cannabis use was associated with impaired response inhibition in the SST, and limited support for impaired inhibition among substance users when controlling for demographics and task-characteristics is found.